Long-term TTF users (>=12 months) showed a trend towards extended OS and PFS compared to shorter-term users, with a significantly lower adherence rate at 3 months in early discontinuation cases (p=0.014).
← all excerpts
10253- ACT-16 OUTCOMES OF MAINTENANCE THERAPY USING TUMOR TREATING FIELDS (TTF) FOR GLIOBLASTOMA AND CHARACTERISTICS FOR CONTINUATION OF TTF MAINTENANCE THERAPY
1
—
—